Latest Insider Transactions at Merck & Co., Inc. (MRK)
This section provides a real-time view of insider transactions for Merck & Co., Inc. (MRK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Merck & Co., Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Merck & Co., Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2024
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
23,296
+14.64%
|
$2,772,224
$119.43 P/Share
|
|
Jan 22
2024
|
Robert M Davis Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
76,510
+18.01%
|
$9,104,690
$119.43 P/Share
|
|
Jan 22
2024
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,896
+14.43%
|
$463,624
$119.43 P/Share
|
|
Jan 22
2024
|
Caroline Litchfield EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,208
+27.39%
|
$2,285,752
$119.43 P/Share
|
|
Nov 09
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Open market or private sale
|
Direct |
2,081
-10.27%
|
$212,262
$102.38 P/Share
|
|
Nov 08
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
43,823
-28.17%
|
$4,601,415
$105.03 P/Share
|
|
Oct 30
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
451
-2.18%
|
$46,002
$102.82 P/Share
|
|
Oct 30
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
915
+4.23%
|
$93,330
$102.82 P/Share
|
|
Aug 14
2023
|
Steven Mizell EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
4,250
-15.63%
|
$463,250
$109.01 P/Share
|
|
Aug 03
2023
|
Chirfi Guindo Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,989
-46.92%
|
$1,888,845
$105.7 P/Share
|
|
Aug 03
2023
|
Chirfi Guindo Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,901
+49.04%
|
$3,874,605
$105.7 P/Share
|
|
Aug 03
2023
|
Steven Mizell EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
4,500
-14.2%
|
$472,500
$105.49 P/Share
|
|
Aug 02
2023
|
Joseph Romanelli President, Human Health Int?l |
SELL
Open market or private sale
|
Indirect |
59
-100.0%
|
$6,313
$107.37 P/Share
|
|
Aug 02
2023
|
Joseph Romanelli President, Human Health Int?l |
SELL
Open market or private sale
|
Direct |
30
-0.15%
|
$3,210
$107.37 P/Share
|
|
May 04
2023
|
Jennifer Zachary EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
19,141
-35.27%
|
$2,239,497
$117.59 P/Share
|
|
May 04
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
436
-2.24%
|
$51,448
$118.22 P/Share
|
|
May 04
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
885
+4.35%
|
$104,430
$118.22 P/Share
|
|
May 04
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-2.21%
|
$52,746
$118.22 P/Share
|
|
May 04
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
907
+4.3%
|
$107,026
$118.22 P/Share
|
|
May 04
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-5.15%
|
$32,922
$118.22 P/Share
|
|
May 04
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
813
+13.04%
|
$95,934
$118.22 P/Share
|
|
May 04
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Open market or private sale
|
Direct |
15,875
-25.78%
|
$1,857,375
$117.53 P/Share
|
|
May 04
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
16,824
+11.26%
|
$1,514,160
$90.15 P/Share
|
|
May 04
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
326
-0.71%
|
$38,468
$118.22 P/Share
|
|
May 03
2023
|
Steven Mizell EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
53,400
-24.77%
|
$6,354,600
$119.01 P/Share
|
|
May 03
2023
|
Steven Mizell EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,000
+19.21%
|
$3,900,000
$75.52 P/Share
|
|
May 03
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-4.87%
|
$27,612
$117.89 P/Share
|
|
May 03
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
689
+12.45%
|
$80,613
$117.89 P/Share
|
|
May 03
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.61%
|
$32,292
$117.89 P/Share
|
|
May 03
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
803
+1.74%
|
$93,951
$117.89 P/Share
|
|
May 02
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Open market or private sale
|
Direct |
7,509
-40.44%
|
$871,044
$116.82 P/Share
|
|
May 02
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,035
+24.53%
|
$337,960
$56.04 P/Share
|
|
May 01
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-1.56%
|
$22,770
$115.47 P/Share
|
|
May 01
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+4.34%
|
$66,355
$115.47 P/Share
|
|
May 01
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.71%
|
$36,685
$115.47 P/Share
|
|
May 01
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
930
+2.03%
|
$106,950
$115.47 P/Share
|
|
May 01
2023
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
524
-2.5%
|
$60,260
$115.47 P/Share
|
|
May 01
2023
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,062
+4.81%
|
$122,130
$115.47 P/Share
|
|
May 01
2023
|
Caroline Litchfield EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-1.33%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+2.63%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-2.16%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+4.21%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-5.05%
|
$25,415
$115.47 P/Share
|
|
May 01
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
643
+12.81%
|
$73,945
$115.47 P/Share
|
|
May 01
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-2.25%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+4.38%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
75,436
-32.81%
|
$8,750,576
$116.03 P/Share
|
|
May 01
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
75,436
+24.7%
|
$4,224,416
$56.04 P/Share
|
|
Apr 28
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
66,163
-29.98%
|
$7,608,745
$115.0 P/Share
|
|
Apr 28
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
66,163
+23.07%
|
$4,102,106
$62.07 P/Share
|